The Wyss Institute at Harvard University will use its organs-on-chips technology to evaluate medical countermeasures against acute radiation syndrome, or ARS, under a $5.6 million grant from the FDA. As part of the contract, scientists at Wyss will test possible countermeasures for ARS on models of radiation damage in bone marrow, gut and lung organs-on-chips.
FDA backs development of radiation-sickness countermeasures
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||